lIs molecular rapid diagnostic test for rifampicin and isoniazid tuberculosis resistance financially feasible? An economic evaluation in Indonesia.
- DOI
- 10.1016/j.ijid.2026.109099
- Published
- 2026 Sep 4
- Container
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijid.2026.109099,
title = {lIs molecular rapid diagnostic test for rifampicin and isoniazid tuberculosis resistance financially feasible? An economic evaluation in Indonesia.},
author = {Dharmawan INIP and Sumroni BIR and Hulwani S and Putri LZ and Husna S and Hakiman APA and Wardoyo MP and Anugrapaksi E and Haryanto B and Fuady A and Burhan E},
year = {2026},
journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
doi = {10.1016/j.ijid.2026.109099},
url = {https://doi.org/10.1016/j.ijid.2026.109099}
}RIS
TY - JOUR TI - lIs molecular rapid diagnostic test for rifampicin and isoniazid tuberculosis resistance financially feasible? An economic evaluation in Indonesia. AU - Dharmawan INIP AU - Sumroni BIR AU - Hulwani S AU - Putri LZ AU - Husna S AU - Hakiman APA AU - Wardoyo MP AU - Anugrapaksi E AU - Haryanto B AU - Fuady A AU - Burhan E PY - 2026 JO - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases DO - 10.1016/j.ijid.2026.109099 UR - https://doi.org/10.1016/j.ijid.2026.109099 ER -
APA
INIP, D., BIR, S., S, H., LZ, P., S, H., APA, H., MP, W., E, A., B, H., A, F., & E, B. (2026). lIs molecular rapid diagnostic test for rifampicin and isoniazid tuberculosis resistance financially feasible? An economic evaluation in Indonesia.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2026.109099
Source records
- pubmed · retrieved 2026-09-25T08:53:41.737Z